Search Results - Hongbo Du

Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carc... by Shuo Li, Shuo Li, Hongbo Du, Hongbo Du, Da'nan Gan, Da'nan Gan, Xiaoke Li, Xiaoke Li, Xiaobin Zao, Xiaobin Zao, Yong'an Ye, Yong'an Ye

Connect to this object online.

Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model by Shuo Li, Shuo Li, Zhiguo Li, Hongbo Du, Hongbo Du, Xiaobin Zao, Xiaobin Zao, Da'nan Gan, Da'nan Gan, Xianzhao Yang, Xianzhao Yang, Xiaoke Li, Xiaoke Li, Yufeng Xing, Yong'an Ye, Yong'an Ye

Connect to this object online.

Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma by Xu Cao, Hening Chen, Zhiguo Li, Xiaoke Li, Xiaoke Li, Xianzhao Yang, Xianzhao Yang, Qiushuo Jin, Qiushuo Jin, Yijun Liang, Jiaxin Zhang, Jiaxin Zhang, Meiyue Zhou, Ningyi Zhang, Guang Chen, Guang Chen, Hongbo Du, Hongbo Du, Xiaobin Zao, Xiaobin Zao, Yong'an Ye, Yong'an Ye

Connect to this object online.

Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine by Shihao Zheng, Shihao Zheng, Chengyuan Xue, Chengyuan Xue, Size Li, Size Li, Xiaobin Zao, Xiaobin Zao, Xiaoke Li, Xiaoke Li, Qiyao Liu, Qiyao Liu, Xu Cao, Xu Cao, Wei Wang, Wei Wang, Wenying Qi, Wenying Qi, Hongbo Du, Hongbo Du, Peng Zhang, Yongan Ye, Yongan Ye

Connect to this object online.

The Chinese herbal KangXianYiAi formula inhibits hepatocellular carcinoma by reducing glutathione and inducing ferroptosis by Xiaobin Zao, Xu Cao, Yijun Liang, Jiaxin Zhang, Hening Chen, Ningyi Zhang, Ruijia Liu, Qian Jin, Yue Chen, Xiaoke Li, Hongbo Du, Guang Chen, Li Hou, Yong'an Ye

Connect to this object online.